| General Information of Drug Metabolite (DM) (ID: DM003364) |
| DM Name |
AG-1549 Metabolite C22
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A1 (Cyp3a1)
|
DMEN096
|
| Oxidation - Oxidationn |
AG-1549
|
[1] |
|
Cytochrome P450 3A2 (Cyp3a2)
|
DMEN097
|
| Oxidation - Oxidationn |
AG-1549
|
[1] |
|
|
|
|
|
|
|
| DME(s) Metabolizing This DM |
| DME Name |
DME ID |
Product |
Reaction |
Related Drug |
REF |
|
Cytochrome P450 3A1 (Cyp3a1)
|
DMEN096
|
| Unclear - Unclear |
AG-1549
|
[1] |
|
Cytochrome P450 3A2 (Cyp3a2)
|
DMEN097
|
| Unclear - Unclear |
AG-1549
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| AG-1549 |
DR0267
|
Phase 1 |
Human immunodeficiency virus infection |
|
|
| References |
| 1 |
Evaluation of capravirine as a CYP3A probe substrate: in vitro and in vivo metabolism of capravirine in rats and dogs
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
